Bristol-Myers Squibb Company (NYSE:BMY) Q2 2023 Earnings Call Transcript July 27, 2023 8:00 AM ET Company Participants Timothy Power - VP & Head, IR Giovanni Caforio - Chairman & CEO David Elkins - EVP & CFO Christopher Boerner - EVP & Chief Commercialization Officer Adam Lenkowsky - Chief Commercialization Officer Samit Hirawat - EVP & Chief Medical Officer, Global Drug Development Conference Call Participants Chris Shibutani - Goldman Sachs Evan Seigerman - BMO Capital Markets Geoff Meacham - Bank of Amer ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________ FORM 10-Q ___________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to _______ Commission File Number 001-01136 ___________________________ BRISTOL-MYERS SQUIBB COMPANY (Exact ...

Bristol-Myers Squibb Company (NYSE:BMY) Goldman Sachs 44th Annual Global Healthcare Conference June 13, 2023 11:40 AM ET Company Participants Lynelle Hoch - SVP, Global Cell Therapy Franchise Roland Chen - SVP, Cardiovascular Development Conference Call Participants Chris Shibutani - Goldman Sachs Chris Shibutani Okay. Let's get under way. Good morning, everybody. Welcome to the second day of the 44th Annual Goldman Sachs Healthcare Conference. We are very pleased to have Bristol-Myers join us. Today from t ...

Bristol-Myers Squibb Company (NYSE:BMY) Jefferies Healthcare Conference June 8, 2023 9:00 AM ET Company Participants Adam Lenkowsky - Chief Commercialization Officer Conference Call Participants Akash Tewari - Jefferies Akash Tewari All right. Good morning, everyone. Thank you for joining us Day Two of the Jefferies Healthcare Conference here in beautiful Times Square. For those who don't know me, my name is Akash Tewari. I'm a pharma biotech analyst here at Jefferies, and I have the pleasure of hosting Bri ...

Bristol-Myers Squibb Company (NYSE:BMY) 2023 Virtual ASCO Investor Event Conference June 6, 2023 8:00 AM ET Company Participants Tim Power - Investor Relations Samit Hirawat - Chief Medical Officer Adam Lenkowsky - Chief Commercialization Officer Lynelle Hoch - Senior Vice President, Cell Therapy Franchise Lead Rosanna Ricafort - Vice President Cell Therapy Clinical Development Lead Conference Call Participants Chris Schott - JPMorgan Carter Gould - Barclays Matt Phipps - William Blair Dane Leone - Raymond ...

Bristol-Myers Squibb Company (NYSE:BMY) Bank of America Securities 2023 Health Care Conference May 9, 2023 11:40 AM ET Company Participants Adam Lenkowsky - EVP, Head of Commercial Conference Call Participants Geoff Meacham - Bank of America Geoff Meacham Welcome to the first morning of the BofA Healthcare Conference. My name is Geoff Meacham. I'm a senior biopharma analyst, and we are excited to have Bristol-Myers here. And Adam Lenkowsky is here, who recently was promoted to EVP, Head of Commercial. So co ...

Bristol-Myers Squibb Company (NYSE:BMY) Q1 2023 Earnings Conference Call April 27, 2023 8:00 AM ET Company Participants Timothy Power - VP & Head, IR Giovanni Caforio - Chairman & CEO David Elkins - EVP & CFO Christopher Boerner - EVP & Chief Commercialization Officer Samit Hirawat - EVP & Chief Medical Officer, Global Drug Development Conference Call Participants Seamus Fernandez - Guggenheim Andrew Baum - Citi Chris Schott - JPMorgan Steve Scala - Cowen Chris Shibutani - Goldman Sachs Geoff Meacham - Bank ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________ FORM 10-Q ___________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to _______ Commission File Number 001-01136 ___________________________ BRISTOL-MYERS SQUIBB COMPANY (Exac ...

Start Time: 09:50 January 1, 0000 10:22 AM ET Bristol-Myers Squibb Company (NYSE:BMY) Cowen 43rd Annual Healthcare Conference March 07, 2023, 09:50 AM ET Company Participants Samit Hirawat - EVP, Chief Medical Officer, and Drug Development Conference Call Participants Steve Scala - Cowen and Company Mike Nedelcovych - Cowen and Company Steve Scala Welcome to the Cowen conference. Representing the company is Samit Hirawat, who is Executive Vice President and Chief Medical Officer and the Global Head of Drug ...